affinitybiologicals 2024年涨价通知
affinitybiologicals是范围内用于血栓形成和止血研究与诊断的产品的主要制造商。我们的产品包括广泛的抗体，结合物，用于人类和动物分析物免疫测定的抗体对，完整的ELISA试剂盒的VisuLize系列以及包括VisuDep免疫缺陷因子缺乏血浆，VisuCal校准血浆的全系列人类血浆产品和VisuCon控制血浆。服务包括蛋白质纯化，抗体生产，分析开发，定制制造（包括定制冻干和能力验证材料）。
接厂家通知，因成本上涨，affinitybiologicals 产品价格将于2024年1月1日起上涨约5%，2023 年 11 月 30日之前订购和发货的任何产品均适用于2023年价格表。
lifescienceproduction涨价通知
lifescienceproduction涨价通知
接厂家lifescienceproduction通知，因原材料和运输成本的增加，故调整以下产品价格。
| Product Code | Description | Size | Storage Temp |
| S-001A-BR | Foetal Bovine Serum – Aseptically Filled | 500 mL | -20°C or below |
| S-001A-DIA-BR | Foetal Bovine Serum – Aseptically Filled – Dialysed | 500 mL | -20°C or below |
| S-001A-GI-BR | Foetal Bovine Serum – Aseptically Filled – Gamma Irradiated | 500 mL | -20°C or below |
| S-001A-HI-BR | Foetal Bovine Serum – Aseptically Filled – Heat Inactivated | 500 mL | -20°C or below |
| S-001A-UK | Foetal Bovine Serum – Aseptically Filled | 500 mL | -20°C or below |
| S-001A-USDA | Foetal Bovine Serum – Aseptically Filled | 500 mL | -20°C or below |
| S-001B-BR | Foetal Bovine Serum – Aseptically Filled | 100 mL | -20°C or below |
| S-001B-DIA-BR | Foetal Bovine Serum – Aseptically Filled – Dialysed | 100 mL | -20°C or below |
| S-001B-DIA-GI-BR | Foetal Bovine Serum – Aseptically Filled – Dialysed – Gamma Irradiated | 100 mL | -20°C or below |
| S-001B-GI-BR | Foetal Bovine Serum – Aseptically Filled – Gamma Irradiated | 100 mL | -20°C or below |
| S-001B-GI-USDA | Foetal Bovine Serum – Aseptically Filled – Gamma Irradiated | 100 mL | -20°C or below |
| S-001B-HI-BR | Foetal Bovine Serum – Aseptically Filled – Heat Inactivated | 100 mL | -20°C or below |
| S-001B-USDA | Foetal Bovine Serum – Aseptically Filled | 100 mL | -20°C or below |
POA
Storage temperature of -20°C or below
| 尺寸 |
100毫升 |
|---|---|
| 储存温度 |
-20°C 或以下 |
| 船运 |
在干冰上 |
yecuris 20-0029涨价通知
yecuris 20-0029涨价通知
只有 CuRx™ 试剂经过优化并符合 FRG® KO 平台的性能要求。
产品名称：CuRx SMX/TMP、磺胺甲恶唑和甲氧苄啶
•
目录号：20-0037
•产品用途：研究仅使用抗菌剂
•不含动物产品或副产品
•通用名称：SMX-TMP、SM/T
•化学名称：4-氨基-N-（5-甲基-3-异恶唑基）苯磺酰胺）和5-[（3,4,5）-
三甲氧基苯基）甲基]-2,4-嘧啶二胺
•化学式：C10H1 1N3O3S和C14H1 8N4O3
•
化学品系列：抗菌
•
供应方式：每毫升25毫升小瓶80毫克SMX/16毫克TMP
| CuRx™ Nitisinone (NTBC)，0.1 g – 在 FRG® KO 小鼠中验证 | 20-0026 |
| CuRx™ Nitisinone (NTBC)，1.0 g – 在 FRG® KO 小鼠中验证 | 20-0027 |
| CuRx™ Nitisinone (NTBC)，10.0 g – 在 FRG® KO 小鼠中验证 | 20-0028 |
| CuRx™ uPA 肝脏 Tx 增强剂，100 µL – 在 FRG® KO 小鼠中验证 | 20-0029 |
| CuRx™ SMX/TMP 抗生素，25 mL – 在 FRG® KO 小鼠中验证 | 20-0037 |
| CuRx™ 5X 胶原酶溶液，5 x 8 mL 包装 – 在 FRG® KO 小鼠中验证 | 20-0038 |
| CuRx™ FAH pAb，通用，50 µL | 20-0034 |
| 来自 C57/Bl6 小鼠的人源化 FRG®KO 的 HepaCur™ 血清，50µL | 20-0042.1 |
| 来自 NOD 小鼠的人源化 FRG®KO 的 HepaCur™ 血清，50µL | 20-0042.2 |
| 来自 NOD 小鼠的人源化 FRG®KO 的 HepaCur™ 血清，Congenic，50µL | 20-0042.2 |
| 50% 葡萄糖溶液，500mL | 20-0046 |
| 来自 C57Bl/6 小鼠的对照 FRG®KO 的 HepaCur™ 血清，50µL | 20-0048.1 |
| 来自对照 FRG®KO 的 HepaCur™ 血清，用于 NOD 小鼠，50µL | 20-0048.2 |
| 来自人源化 FRG®KO 小鼠的 HepaCur™ 胆汁，50 µL | 20-0049 |
| 来自人源化 FRG®KO 小鼠的 HepaCur™ 冷冻肝脏 | 20-0050 |
| 来自 C57Bl/6 上的人源化 FRG® KO 的 HepaCur™ 血浆，50 µL | 20-0057.1 |
| 来自人源化 FRG® KO on NOD 的 HepaCur™ 血浆，50 µL | 20-0057.2 |
| 来自人源化 FRG® KO on NOD 的 HepaCur™ 血浆，Congenic，50 µL | 20-0057.3 |
| 来自 C57Bl6 小鼠的对照 FRG®KO 的 HepaCur™ 血浆，50 µL | 20-0058.1 |
| 来自 NOD 小鼠的对照 FRG®KO 的 HepaCur™ 血浆，50 µL | 20-0058.2 |
| HepaCur™ 人肝细胞，95%+，纯化，单一供体，冷冻，5M+ | 20-0001 |
| HepaCur™ 小鼠肝细胞、FRG®KO on C57Bl/6、Cryo、5M+ | 20-0023 |
| HepaCur™ 小鼠肝细胞、FRG®KO on NOD、Cryo、5M+ | 20-0025 |
listbio 2020涨价啦，还不快来买？
list biological laboratories公司是世界的科研毒素试剂供应商，其毒素包括霍乱病毒，蛇毒，百日咳毒素等各类毒素 。
listbio 2020涨价啦，还不快来买？
listbio 2020年价格表如下：
| 货号 | 品名 | 规格 | 价格 |
| list104 | Cholera Toxin B Subunit (Choleragenoid) in low salt1 | 0.5mg | 5270 |
| list106 | Cholera Toxin B Subunit Fluorescein Isothiocyanate Conjugate (BFITC) | 0.2mg | 10115 |
| list112 | Cholera Toxin B Subunit Biotin | 0.2mg | 9775 |
| list122 | Enterotoxin Type B from Staphylococcus aureus1,3 | 0.5mg | 7650 |
| list123 | Enterotoxin Type B Toxoid from Staphylococcus aureus 1,3 | 0.25mg | 8330 |
| list139 | Botulinum Neurotoxin Type B Toxoid | 10µg | 6800 |
| list150 | Diphtheria Toxin, unnicked from Corynebacterium diphtheriae | 1mg | 11050 |
| list151 | Diphtheria Toxoid, from Corynebacterium diphtheriae | 0.5mg | 11050 |
| list153 | Toxin A Toxoid from Clostridium difficile | 100µg | 12495 |
| list156 | Pasteurella Multocida Toxin | 50µg | 8075 |
| list160 | Exotoxin A from Pseudomonas aeruginosa | 1mg | 4420 |
| list161 | Shiga Toxin 1 from Escherichia coli1,4,8 | 10µg | 11900 |
| list174 | Anthrax Protective Antigen, Activated (PA 63) from Bacillus anthracis | 0.5mg | 9350 |
| list175 | Anthrax PA 63 – Fluorescein Isothiocyanate Conjugate (PAFITC) | 50µg | 7225 |
| list180 | Pertussis Toxin Islet-Activating Protein Lyophilized in buffer | 50µg | 5695 |
| list181 | Pertussis Toxin Islet Activating Protein Lyophilized (Salt-Free) | 50µg | 5695 |
| list184 | Pertussis Toxin Mutant | 50µg | 5695 |
| list186 | FIMBRIAE 2/3 from B. pertussis | 50µg | 6120 |
| list187 | Pertactin from Bordetella pertussus (69 kDa Protein) | 50µg | 5100 |
| list193 | Tetanus Toxin C Fragment | 10µg | 9860 |
| list201 | LPS from Escherichia coli O111:B4 | 5mg | 3230 |
| list225 | LPS from Salmonella typhimurium | 5mg | 2975 |
| list301 | LPS from Escherichia coli J5 (Rc) | 5mg | 2975 |
| list302 | LPS from Escherichia coli K12, D31m4 (Re) | 5mg | 2975 |
| list304 | LPS from Salmonella minnesota R595 (Re) | 5mg | 2975 |
| list314 | LPS from Escherichia coli K12 strain LCD25 | 1mg | 2975 |
| list401 | Lipid A monophosphoryl from Salmonella minnesota R595 | 1mg | 3485 |
| list421 | Ultra Pure LPS from Escherichia coli O111:B4 | 1mg | 3740 |
| list423 | Ultra Pure LPS from Escherichia coli O55:B5 | 1mg | 3825 |
| list433 | LISTÔ HPTÔ, LPS, highly purified Escherichia coli O113 LPS | 1mg | 4250 |
| list434 | Ultra Pure LPS from Salmonella minnesota R595 (Re) | 1mg | 3485 |
| list520 | SNAPtide® Peptide Substrate (o-Abz/Dnp) (U.S. Patent #6,504,006) | 200nmoles | 10200 |
| list521 | SNAPtide® Peptide Substrate (FITC/DABCYL) (U.S. Patent #6,504,006) | 200nmoles | 8500 |
| list523 | SNAPtideÒ Peptide Substrate flP6 (DABCYL/5-IAF), U.S. Patent Pending #61/252,675 | 200nmoles | 8500 |
| list525 | Control Peptide for SNAPtideÒ #520 | 200nmoles | 8500 |
| list526 | Control Peptide for SNAPtide® #521 | 200nmoles | 8500 |
| list528 | Unquenched Calibration Peptide for SNAPtide® 521 | 50nmoles | 2890 |
| list529 | Unquenched Calibration Peptide for SNAPtide® 520 | 50nmoles | 2890 |
| list530 | MAPKKide® Peptide Substrate (o-Abz/Dnp) | 200nmoles | 5100 |
| list531 | MAPKKide® Peptide Substrate (DABCYL/FITC) | 200nmoles | 5100 |
| list532 | MAPKKide® Plus (AMC) Specific Substrate for Anthrax Lethal Factor | 100nmoles | 4250 |
| list539 | Unquenched Calibration Peptide for MAPKKideÒ 530 | 50nmoles | 2890 |
| list540 | VAMPtide® Peptide Substrate (o-Abz/Dnp) | 200nmoles | 8500 |
| list541 | VAMPtide® Peptide Substrate (FITC/DABCYL) | 200nmoles | 8500 |
| list542 | VAMPtide® Peptide Substrate (PL 150, Pya/Nop) | 200nmoles | 8500 |
| list549 | Calibration Fluorophore for VAMPtideÒ 540 | 100nmoles | 2890 |
| list550 | SNAP Etide® Peptide Substrate (o-Abz/Dnp) | 100nmoles | 6970 |
| list559 | SNAP Etide® Unquenched Calibration Peptide for Product #550 | 50nmoles | 4250 |
| list560 | SYNTAXtideÒ Peptide Substrate (o-Abz/Dnp) for C. botulinum Type C | 200nmoles | 8500 |
| list703 | Anti-Cholera Toxin B Subunit (Goat) | 0.1ml | 3230 |
| list752 | Anti-Toxin A from Clostridium difficile (Goat) | 0.5ml | 3315 |
| list760 | Anti-Exotoxin A (Goat) | 0.5ml | 3400 |
| list781 | Anti-Protective Antigen from Bacillus anthracis (Goat) affinity purified, Liquid6,7 | 0.1mg | 7055 |
| list100B | Cholera Toxin (Azide Free)1 | 1mg | 3570 |
| list116L | Alpha Toxin from C. septicum,6,7 | 50µg | 5100 |
| list126A | Epsilon Toxin from C. perfringens1,4,8 | 0.1mg | 6120 |
| list128A | Botulinum Neurotoxin Type A Complex from Clostridium botulinum1,3 | 10µg | 2890 |
| list128C | Botulinum Neurotoxin Type A Complex from Clostridium botulinum1,3 | 100µg | 5440 |
| list130A | Botulinum Neurotoxin Type A from Clostridium botulinum1,3 | 10µg | 5440 |
| list130B | Botulinum Neurotoxin Type A from Clostridium botulinum1,3 | 100µg | 13600 |
| list133L | Botulinum Neurotoxin Type A Toxoid, Liquid6,7 | 10µg | 5440 |
| list136A | Botulinum Neurotoxin Type B. from Clostridium botulinum 1,3 | 10µg | 5100 |
| list136B | Botulinum Neurotoxin Type B, from Clostridium botulinum1,3 | 100µg | 17000 |
| list138A | Botulinum Neurotoxin Type B Complex, Nicked, from Clostridium botulinum1,3 | 10µg | 2890 |
| list138B | Botulinum Neurotoxin Type B Complex, Nicked, from Clostridium botulinum1,3 | 100µg | 7225 |
| list140A | Botulinum Neurotoxin Type E, Nicked, Complex from Clostridium botulinum1,3 | 10µg | 2890 |
| list140B | Botulinum Neurotoxin Type E, Nicked, Complex from Clostridium botulinum1,3 | 100µg | 8925 |
| list141A | Botulinum Neurotoxin Type E, Nicked, from Clostridium botulinum1,3 | 10µg | 8075 |
| list146A | Botulinum Neurotoxin Type D, Nicked, Recombinant from Clostridium botulinum1,3 | 10µg | 5355 |
| list149A | Diphtheria Toxin CRM Mutant | 0.25 mg | 8500 |
| list152C | Toxin A from Clostridium difficile | 100µg | 9010 |
| list154A | Toxin B Toxoid from Clostridium difficile | 20µg | 3060 |
| list15 | Toxin B from Clostridium difficile | 2µg | 2975 |
| list155B | Toxin B from Clostridium difficile | 20µg | 8755 |
| list155L | Toxin B from Clostridium difficile, Liquid6,7 | 50µg | 11050 |
| list157A | Binary Toxin from Clostridium difficile, A Subunit | 20µg | 5950 |
| list159A | Glutamate Dehydrogenase (GDH) from Clostridium difficile6,7 | 0.1mg | 4930 |
| list162L | Shiga Toxin 2 from Escherichia coli1,4,5 | 10µg | 11050 |
| list169B | Anthrax Lethal Factor (LF-A),Recombinant from Bacillus anthracis Native Sequence | 1mg | 13175 |
| list169L | Anthrax Lethal Factor (LF-A),Recomb.from Bacillus anthracis 5,7 | 0.2 mg | 6120 |
| list171E | Anthrax Protective Antigen (PA), Recombinant from Bacillus anthracis | 0.5mg | 9180 |
| list172B | Anthrax Lethal Factor (LF), Recombinant from Bacillus anthracis | 1mg | 13175 |
| list172L | Lethal Factor, Recomb from Bacillus anthracis, froz liq 5,7 | 1.0 mg | 12750 |
| list173B | Anthrax Edema Factor (EF), Recombinant Mutant S447N from Bacillus anthracis | 0.5mg | 16150 |
| list176A | Anthrax Lethal Factor (LF), Recombinant, Mutant E687C from Bacillus anthracis | 0.1mg | 5100 |
| list176B | Anthrax Lethal Factor (LF), Recombinant, Mutant E687C from Bacillus anthracis | 1mg | 16150 |
| list177A | Anthrax Protective Antigen Fragment (PA 20) from Bacillus anthracis | 50µg | 5950 |
| list177B | Anthrax Protective Antigen Fragment (PA 20) from Bacillus anthracis | 0.25mg | 11390 |
| list178A | Anthrax Edema Factor (EF), Recombinant from Bacillus anthracis | 0.1mg | 3060 |
| list179A | Pertussis Toxin Islet Activating Protein (in glycerol)6,7 | 50µg | 5100 |
| list188L | Adenylate Cyclase Toxin from B. pertussis, Recombinant, Frozen Liquid5,7 | 50µg | 5270 |
| list190A | Tetanus Toxin2 | 25µg | 2890 |
| list190B | Tetanus Toxin2 | 100µg | 9350 |
| list191A | Tetanus Toxoid | 25µg | 4930 |
| list191B | Tetanus Toxoid | 100µg | 14280 |
| list196A | C-fragment, FITC Conjugate | 10µg | 7055 |
| list203A | LPS, Escherichia coli O55:B5 | 2.5 mg | 3230 |
| list500A | SNAP-25 Recomb Protein Substrate for C. botulinum Type A and E Neurotoxin | 100µg | 5780 |
| list510A | GST Synaptobrevin-2 Protein Recomb. Protein Substrate for C. botulinum Type B,D and F | 100µg | 5950 |
| list610A | Botulinum Neurotoxin Type A Light Chain, Recombinant1 | 10µg | 4760 |
| list611A | Botulinum Neurotoxin Type A Light Chain, GST Fusion, Recombinant1 | 15µg | 4760 |
| list612A | Botulinum Neurotoxin Type A Heavy Chain, Recombinant, Binding Domain1 | 50µg | 4760 |
| list613A | Botulinum Neurotoxin Type A Heavy Chain, Recombinant, Binding Domain, GST Fusion1 | 50µg | 4760 |
| list620A | Botulinum Neurotoxin Type B Light Chain, Recombinant1 | 10µg | 8500 |
| list622A | Botulinum Neurotoxin Type B Heavy Chain, Recombinant, Binding Domain1 | 50µg | 4760 |
| list623A | Botulinum Neurotoxin Type B Heavy Chain, Recombinant, Binding Domain, GST Fusion1 | 50µg | 4760 |
| list62 | Botulinum Neurotoxin Type C Light Chain, Recombinant1 | 10µg | 8500 |
| list630A | Botulinum Neurotoxin Type D Light Chain, Recombinant1 | 10µg | 5695 |
| list690B | Receptor for C. botulinum Type A Neurotoxin GST-SV2c luminal domain (U.S. Patent #8,476,024) |
100nmoles | 6970 |
| list730A | Anti-Botulinum Neurotoxin, Type A (Chicken lgY), Liquid6,7 | 0.1mg | 5780 |
| list731L | Anti-Botulinum Neurotoxin, Type A (Mouse lgG monoclonal F1-40), Liquid6,7 | 0.1mg | 6120 |
| list736A | Anti-Botulinum Type B (Chicken lgY), Liquid6,7 | 0.1mg | 6120 |
| list753A | Anti-Clostridium difficile Toxin A (Chicken lgY), Liquid6,7 | 0.1mg | 5780 |
| list754A | Anti-Clostridium difficile Toxin B (Chicken lgY), Liquid6,7 | 0.1mg | 5780 |
| list756A | Anti-Clostridium difficile Glutamate Dehydrogenase, lgY, Liquid6,7 | 0.1mg | 5780 |
| list757A | Anti-Clostridium difficile Binary Toxin A subunit (Chicken lgY), Liquid6,7 | 0.1mg | 5950 |
| list758A | Anti-Clostridium difficile Binary Toxin B subunit (Chicken lgY), Liquid6,7 | 0.1mg | 5780 |
| list759A | Biotinylated Anti-Clostridium difficile Binary Toxin B subunit (Chicken lgY), Liquid6,7 | 0.1mg | 5780 |
| list761L | Anti-Shiga Toxin 1 (Rabbit), lgG, Liquid6,7 | 0.5mg | 3400 |
| list765L | Anti-Shiga Toxin 2 (Rabbit), IgG, Liquid6,7 | 0.5mg | 2890 |
| list766L | Anti-Shiga Toxin, Camelid Antibody, VHH, Liquid6,7 | 0.5mg/ml | 5950 |
| list768L | Biotinylated Anti-Lethal Factor from B. anthracis, IgY, Liquid6,7 | 0.1mg | 6120 |
| list769B | Anti-Lethal Factor from Bacillus anthracis (Chicken lgY), Liquid6,7 | 0.2mg | 8500 |
| list771B | Anti-Protective Antigen from Bacillus anthracis (Goat) | 1mg | 2890 |
| list772B | Anti-Lethal Factor from Bacillus anthracis (Goat) | 1.0 mg | 2890 |
| list773L | Anti-Edema Factor from Bacillus anthracis (Goat), Liquid6,7 | 1mg | 2975 |